Abstract
Background
Despite the availability of many gastric surgery techniques to reduce obesity and its associated comorbidities, most of these procedures can result in life-threatening conditions including lifetime chronic illnesses and death. Vertical sleeve gastrectomy and Roux-en-Y gastric bypass have been reported to improve obesity-related comorbidities such as T2DM, but the long-term efficacy of these two procedures is unknown, and their significant impact on long-term weight loss was diminished by complications as reported in previous studies. Recently, laparoscopic biliopancreatic diversion with duodenal switch (BPD/DS) was developed to achieve sustained weight loss (Buchwald et al. Am J Med. 122:248–56, 2009; Sjöström et al. N Engl J Med. 351:2683–93, 2004) as well as an improvement in comorbid conditions, such as T2DM and hypertension (Buchwald et al. in Am J Med. 122:248–56, 2009; Dorman et al. Surgery. 152:758–65, 2012). The malabsorptive strategy of bypassing portions of the small intestine and delivering nutrients directly to the ileum may promote weight loss by enhanced activation of a negative feedback mechanism known as the “ileal brake” (Näslund et al. J Gastrointest Surg. 5:556–67, 2001). The purpose of this pilot study was to evaluate the safety, reproducibility, and efficiency of a new surgical bariatric model of laparoscopic intestinal bipartition (LIB) in patients with a BMI between 35 and 40 kg/m2. The setting was in university hospitals.
Methods
Between January 2011 and September 2012, seven patients were enrolled in the study and underwent the LIB procedure. One patient was operated by LIB for morbid obesity with comorbidities, especially T2DM, without any previous bariatric or gastric surgery. Six patients underwent the surgery after a sleeve gastrectomy for ≥ 4 years with a recurrence of obesity and diabetes.
Results
The comorbidity factors decreased to the normal values in all patients at 6 months, 1 year, and 5 years postoperatively. The percentage of total weight loss was 21.1% at 6 months, 22.6% at 1 year, and 15.6% at 5 years. Weight excess was significantly lower at 6-month, 1-year, and 5-year postoperatively compared with baseline (p < 0.001). Comparison of comorbidity values at 6 months, 1 year, and 5 years did not show any significant differences.
Conclusion
Laparoscopic intestinal bipartition produced a total recovery from obesity-related comorbidities, especially T2DM and EWL without any signs of nutritional deficiency, although the 5-year follow-up is ongoing in order to demonstrate the efficacy and long-term durability of this procedure.
References
Lara MD, Kothari SN, Sugerman HJ. Surgical management of obesity: a review of the evidence relating to the health benefits and risks. Treat Endocrinol. 2005;4:55–64.
Willaert W, Henckens T, Van De Putte D, et al. Life-threatening side effects of malabsorptive procedures in obese patients necessitating conversion surgery: a review of 17 cases. Acta Chir Belg. 2012;112:268–74.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.
Dorman RB, Rasmus NF, al-Haddad BJ, et al. Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery. 2012;152:758–65.
Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.
Rao RS, Kini S. Diabetic and bariatric surgery: a review of the recent trends. Surg Endosc. 2012;26:893–903.
Nelson DW, Blair KS, Martin MJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg. 2012;147:847–54.
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.
Livingston EH. Primum non nocere. Ann Intern Med. 2011;155:329–30.
Escalona A, Yanez R, Pimentel F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010;6:126–31.
Nanni G, Familiari P, Mor A, et al. Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion. Obes Surg. 2012;22:1897–902.
Dumon KR, Murayama KM. Bariatric surgery outcomes. Surg Clin North Am. 2011;91:1313–38.
Castagneto M, Mingrone G. The effect of gastrointestinal surgery on insulin resistance and insulin secretion. Curr Atheroscler Rep. 2012;14:624–30.
Näslund E, Hellström PM, Kral JG. The gut and food intake: an update for surgeons. J Gastrointest Surg. 2001;5:556–67. Review
Van Citters GW, Lin HC. The ileal brake: a fifteen-year progress report. Curr Gastroenterol Rep. 1999;1:404–9. Review
Doggrell SA, Chan V. Bariatric surgery or medicine for type 2 diabetes? Expert Opin Pharmacother. 2012;13:2249–53.
Maljaars J, Peters HP, Masclee AM. Review article: the gastrointestinal tract: neuroendocrine regulation of satiety and food intake. Aliment Pharmacol Ther. 2007;2:241–50.
Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis. 2013;9(3):398–403.
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.
Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16(10):1371–9.
Santoro S. From bariatric to pure metabolic surgery: new concepts on the rise. Ann Surg. 2015;262:79–80.
Santoro S. Stomachs: does the size matter? Aspects of intestinal satiety, gastric satiety, hunger and gluttony. Clinics. 2012;67(4):301–3.
Melissas J, Peppe A, Askoxilakis J, et al. Sleeve gastrectomy plus side-to-side jejuno ileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation. Obes Surg. 2012;22(7):1104–9.
Alamo Alamo M, Sepúlveda Torres C, Zapata Perez L. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg. 2006;16(3):353–8. https://doi.org/10.1381/096089206776116534.6.
Sepulveda M, Gellona J, Herrera M, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index. Obes Surg. 2012;22(7):1097–103. https://doi.org/10.1007/s11695-012-0652-x.
Sepulveda M, Alamo M, Saba J, et al. Roux-en-Y gastric bypass versus sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes. Results at 12 months of follow-up. Surg Obes Relat Dis. 2015;11(Supplement):S68. https://doi.org/10.1016/j.soard.2015.08.081.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interests.
Statement of Informed Consent
“Informed consent was obtained from all individual participants included in the study.”
Statement of Human and Animal Rights
“Informed consent was obtained from all individual participants included in the study.”
Rights and permissions
About this article
Cite this article
Sarkis, R., Khazzaka, A. & Kassir, R. Pilot Study of a New Model of Bariatric Surgery: Laparoscopic Intestinal Bipartition—Safety and Efficacy Against Metabolic Disorders. OBES SURG 28, 3717–3723 (2018). https://doi.org/10.1007/s11695-018-3483-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-3483-6